Produkty 35109-93-4

CAS 35109-93-4 występuje w naszej ofercie pod nazwami: Adynerin, Adynerin/ 98.12% (existing batch purity), Adynerin, 99.73%. Oferty producentów: GLPBio, TargetMol, Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 1mg, 10mg, 5mg, 25mg, 50mg, 2mg, 20mg, 5 mg.

Adynerin
GLPBio, Biosynth, Chemat
  • opakowanie: 1mg, 10mg, 5mg, 25mg
  • Warianty: 9
od 789,20
Zobacz produkt
Adynerin/ 98.12% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 5
od 1009,99
Zobacz produkt
Adynerin, 99.73%
MedChemExpress
  • opakowanie: 5 mg, 10 mg
  • Warianty: 2
od 2089,06
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

3-[(1S,3R,6R,7R,10R,11S,14S,16R)-14-[(2R,4R,5S,6R)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadecan-6-yl]-2H-furan-5-one (CAS 35109-93-4) to związek chemiczny o wzorze sumarycznym C30H44O7 i masie molowej 516.7 g/mol. Nazwa systematyczna IUPAC: 3-[(1S,3R,6R,7R,10R,11S,14S,16R)-14-[(2R,4R,5S,6R)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadecan-6-yl]-2H-furan-5-one. InChIKey: BYZQVAOKDQTHHP-QFUJVLJYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC30H44O7
Masa molowa516.7 g/mol
Nazwa IUPAC3-[(1S,3R,6R,7R,10R,11S,14S,16R)-14-[(2R,4R,5S,6R)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadecan-6-yl]-2H-furan-5-one
InChIKeyBYZQVAOKDQTHHP-QFUJVLJYSA-N
SMILESC[C@@H]1[C@@H]([C@@H](C[C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CC[C@]45[C@@H]3CC[C@]6([C@]4(O5)CC[C@@H]6C7=CC(=O)OC7)C)C)OC)O

Dane obliczone przez PubChem (NCBI)

Synonimy: ADYNERIN, orb1218126, orb1297569, 3-[(2,6-dideoxy-3-o-methylhexopyranosyl)oxy]-8,14-epoxycard-20(22)-enolide
Izomery (ten sam wzór sumaryczny)
(2S,8S,9R,10R,13R,14S,16R,17R)-17-[(E,2R)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthrene-3,11-dione C30H44O7
(2R,6R)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid C30H44O7
(2R,6R)-6-[(5R,7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoic acid C30H44O7
(Z)-2-methyl-4-oxo-6-[(3S,5R,7S,10S,13R,14R,15S,17R)-3,7,15-trihydroxy-4,4,10,13,14-pentamethyl-11-oxo-1,2,3,5,6,7,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]hept-5-enoic acid C30H44O7
3-[6-(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy-9,13-dimethyl-17-oxo-14-tetracyclo[11.3.1.01,10.04,9]heptadecanyl]-2H-furan-5-one C30H44O7
(E,4S,6R)-6-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11,15-dioxo-2,3,5,6,7,12,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-4-hydroxy-2-methylhept-2-enoic acid C30H44O7